Abstract 2366: HDAC inhibition improves immune checkpoint inhibitor efficacy in renal cell carcinoma
Justin A. Budka(Gilead Sciences (United Kingdom)), Роберто Пили(Jacobs Institute), Nur P. Damayanti(University of Indianapolis)
Cited by 1
Related Papers
Vorinostat in advanced prostate cancer patients progressing on prior chemotherapy (National Cancer Institute Trial 6862)
|Cancer|2009|148
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
|Nucleic Acids Research|2014|123
Impact of tumor microenvironment on efficacy of anti-CD19 CAR T cell therapy or chemotherapy and transplant in large B cell lymphoma
|Nature Medicine|2024|114
Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma
|Clinical Cancer Research|2018|95